ABSTRACT
produce general anesthesia.
There has, however, been a paradigm shift in the study of anesthetic mechanisms, and there are encouraging signs that the 99Os will be as important as the 1890s for understanding anesthetic drugs. In the 1890s, Meyer and Overton (1) proposed the relationship that dominated thinking in this area throughout this century. They noted that the potency of an anesthetic is proportional to its lipid solubility. This relationship was extended to implicate the lipid regions of the nerve cell, particularly the lipid bilayer of the plasma membrane, as the site of action of anesthetics. However, despite intensive study, the action of anesthetics on lipid structure has failed to provide a mechanism for changes in neuronal function that could account for anesthesia.
More recently, emphasis has shifted to the study of anesthetic actions on specific proteins that determine neuronal excitability. The search for proteins that are affected by a wide range of anesthetic agents and are important for neuronal function has focused on the ligand-gated ion channels (2, 3) . This superfamily of ion channels represents the site of action of the major inhibitory y-aminobutyric acid (GABA)3 and glycine) and excitatory (glutamate and aspartate) neurotransmitters of the central nervous system (CNS). Anesthetic-induced changes in the functioning of these receptor systems would change the balance between inhibitory and excitatory influences in the CNS, making the ligand-gated ion channels logical candidates for study. Initial studies of anesthetic action on these receptors used brain preparations containing many different types of receptors, as well as pre-and postsynaptic elements (4) (5) (6) . These pioneering studies, although demonstrating that both inhibitory and excitatory synaptic transmission are sensitive to a variety of anesthetics, did not define the site of anesthetic action.
A major advance in the reductionist approach to studying synaptic mechanisms occurred in the late l980s and early 1990s when the cDNAs that code for the protein subunits of these ligand-gated ion channels were cloned and sequenced. 
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. 4 Fig. 1 where the potentiation of GABA actions by receptor is similar to that of a-amino-3-hydroxy-5-methyl-4-isoxalone propionic acid (AMPA) receptors (see below) in that short-chain alcohols are effective inhibitors, but longchain alcohols, volatile anesthetics, pentobarbital, and propofol produce little or no effect. However, these receptors are quite different in many respects from other GABAA receptors. For example, they share only 30-38% homology with most other subunits, and homomeric p receptors are resistant to bicuculline and are found primarily in the retitia. In fact, it has been suggested that they should be termed GABAC receptors (12). The #{246}subunit also has a low homology with otherGABA receptor subunits. Although it forms functional homomeric receptors, it is not known whether these channels are affected by anesthetics other than pentobarbital. Incorporation of the 6 subunit into heteromeric receptors (containing a, , and y subunits) does not alter the sensitivity of these receptors to pentobarbital (15) . Third, the expression system does not appear to determine the actions of the compounds tested to date, although direct comparisons are limited. Xenopus oocytes, human embryonic kidney cells (HEK293), and mouse fibroblasts (Ltk cells) have been transfected with several subunit combinations for anesthetic studies. Pentobarbital has been tested in all three systems and the enhancement of GABA action is similar for these three cell types as well as for neuronal GABAA responses. Similar octanol sensitivity is observed on receptors expressed in oocytes and HEK cells.
GABAA RECEPTORS
In regard to the GABAA receptor, two other issues arise. One is the direct activation of the channel by anesthetics, It is clear that barbiturates, 3a-hydroxy-5a-pregnan-20-one (DHP), and propofol can activate the channel in the absence of GABA (16, 17) , but volatile anesthetics generally do not activate the channel directly (10, 13). The direct actions of pentobarbital and propofol appear to require a subunit; thus, they display much more subunit specificity than the enhancement of GABA action and likely represent a distinct site on the receptor complex (17) . However, the concentrations required to produce the direct actions are generally greater than those required to potentiate GABA actions. This observation, together with the finding that volatile anesthetics do not activate the channel, suggests that this phenomenon may not be relevant to anesthesia.
A second issue is the action of low, nonanesthetic concentrations of ethanol on GABAA receptors. There are numerous reports that ethanol at concentrations of 5-30 mM (e.g., 10-to 60-fold less than the anesthetic concentration) enhances GABA action (18, 19). The effects of anesthetic concentrations of ethanol display no subunit specificity, but the low-dose actions require a subunit (20). In addition, there is evidence that phosphorylation of the y2L splice variant is required for sensitivity to low concentrations ofethanol (21). (In Table 1 , the short and long splice variants of the 2 subunit are not distinguished because there is no indication that they differ in sensitivity to anesthetic concentrations of any of these drugs.) However, the effects of ethanol on recombinant GABAA receptors are controversial, and several investigators have not found enhancement of GABA action by subanesthetic concentrations of ethanol (e.g., 10-100mM) (22-24). This issue is discussed in detail elsewhere (18,25).
Another important consideration for any candidate site of anesthetic action is the effect (or lack thereof) of nonanesthetic drugs. Recently, several fluorinated hydrocarbons were found to be nonanesthetic even though they reach the brain in concentrations that would be predicted (from the Meyer-Ovei-ton relationship) to be anesthetic (26, 27). In addition, some other membrane-active agents are not anesthetic (28). Although solubility in olive oil is sufficient to predict the potency of most anesthetics, it is not capable of classifying these compounds as nonanesthetics. Accordingly, it was of interest to determine whether recombinant GABAA receptors are superior to olive oil as predictors of anesthetic potency. In contrast to anesthetics, structurally similar nonanesthetics do not enhance GABA action, even at concentrations predicted by Meyer-Overton to be anesthetic (10,28,29) (see Table 5 ). In summary, recombinant GABAA receptors are sensitive to all anesthetics tested so far but are not affected by structurally related nonanesthetics.
The enhancement is extremely dependent on the concentration of GABA, and appreciable (e.g., 200-600%) enhancement can be obtained at or below the anesthetic EC3o if the GABA concentration is low (e.g., EC.1o). With high concentrations of GABA, there is little or no enhancement by most anesthetics, and in the case ofenflurane there is a slight inhibition of GABA action ( Fig. 1)  (9-11, 30) . Enhancement of GABA action by anesthetics does not require any specific subunit and is similar for a wide variety of different subunit combinations, although it is not found with homomeric p subunits. It is possible that the anesthetics act directly on one or more sites that are conserved among the a, , and ysubunits but not found in the psubuttits (13). (Table 5 ).
GLYCINE RECEPTORS
In summary, inhibition of AMPA and kainate receptors may be important for the anesthetic and intoxicating effects of ethanol and other short-chain alcohols, but studies of recombinant receptors suggest that the drug sensitivity of AMPA responses is not sufficient for them to play a primary role in anesthetic actions of volatile or intravenous agents. However, the sensitivity of AMPA receptors to ethanol can be increased by elevation of intracellularcalcium (38). Ifthis is also true for inhibition with 100 mM) (41).
However, homomeric is not affected by ethanol, and 1 with #{163}3 shows only 19% inhibition by 100mM ethanol (41). It is not clear why homomeric rat Ri receptors were reported to be sensitive to ethanol, whereas the equivalent mouse receptors were not, although these homomeric receptors express poorly and it is difficult to estimate drug effects on the small currents observed.
In summary, as for AMPA receptors, inhibition of NMDA receptors may be important for anesthetic and intoxicating effects of ketamine, ethanol, and other short-chain alcohols, but there are insufficient studies to define their role in anesthetic actions of volatile agents. Studies of ethanol on The FASEB Journal HARRIS ET AL.
recombinant NMDA receptors suggest that not all subunits are equally sensitive. It will be of interest to see if this result can be extended to volatile anesthetics.
5HT3 RECEPTORS
The 5HT3 receptor is a cation channel activated by serotonin that has a discrete localization in brain (e.g., area postrema). Endogenous 5HT3 receptor responses are enhanced by anesthetic concentrations of ethanol and diethyl ether but inhibited (weakly) by pentobarbital (42). Titus far, only one 5HT3 subunit has been cloned, and initial studies demonstrate that most anesthetic agents enhance the function of this homomeric receptor expressed in Xenopus oocytes (43). In this study, ethanol, butanol, isoflurane, halothane, and F3 all enhanced the action of serotonin on 5HT3 receptors at levels corresponding to one-to twofold the anesthetic concentration. However, propofol was ineffective even at 30-fold the anesthetic concentration.
Enhancement of 5HT3 receptor function is unlikely to be responsible for anesthesia but may cause the nausea and vomiting produced by many anesthetic agents (43). This suggestion is strengthened by the observation that propofol produces less nausea than most anesthetics (44) and does not enhance 5HT3 receptorfunction.
OTHER RECEPTORS
The only member of the superfamily of ligand-gated. ion channels not discussed in this review is the nicotinic acetylcholine receptor (nAChR). Although there is considerable evidence for effects of anesthetics on the nAChR (3,45), we did not find any report of effects of these drugs on recombinant nAChR. An ATP-activated cation channel has recently been cloned but is structurally unrelated to the ligand-gated ion channels discussed here (46, 47). Anesthetic sensitivity of the recombinant receptor has not been reported, but the neuronal receptor is inhibited by ethanol and propanol but not by longer chain alcohols or the anesthetic trichloroethanol (48). These results suggest that this receptor is not a site of anesthetic action, but studies with volatile anesthetics on the cloned receptors are warranted.
FUTURE DIRECTIONS
The results summarized in this article provide several possibilities fordefining receptor regions, or perhaps even specific amino acids, that are required for anesthetic action. For example, demonstration of distinct drug actions on two homologous proteins allows use of chimeric proteins to define regions critical for drug action. Thus, it might be possible to show the site of propofol action by making chimeric receptors based on the propofol-sensitive i subunit of the GABAA receptor in which regions have been exchanged with the propofol-insensitive 5-HT3 receptor.
For the purpose of discussion, let us assume that exchange of a specific transmembrane region (e.g., TM3) between these receptors prevents propofol action on the i subunit but confers sensitivity to the 5-HTs receptor. This could be followed by mutation of specific amino acids in this region with the hope of identifying the amino acids responsible for propofol action. One of the many pitfalls in this approach is that the chimeric cDNAs may not express functional proteins. This is more likely to be a problem if the receptors have low homology, as is the case with the 3i GABAA receptor and the 5-HT3 receptor. A better choice would probably be the p and 3i subunits, which have about 37% sequence identity at the amino acid level. In addition, receptors formed from the psubunits are resistantto propofol and pentobarbital,but those formed from I subunits are sensitive to both these drugs. Another promising possibility is the study of chimeras of GluR3 and G1uR6 subunits. Because volatile anesthetics inhibit the function of receptors formed from G1uR3 subutiits, but enhance function of GIuR6 receptors, chimeras of these two subunits should be able to define the subunit regions or even the amino acids responsible forthese distinct actions of anesthetics.
An important issue is how to interpret the results of chimera/mutagenesis studies. Takingour hypothetical result of a single amino acid conferring or abolishing propofol sensitivity, can we conclude that this amino acid is a critical part of the propofol binding site on the channel?
Can this approach define a "receptor" for this anesthetic? For many drugs, the next step is straightforward:
measuring the binding of radioactive drug to cells transfected with the mutated receptor will determine whether the mutation alters the drug-receptor interaction or another step in the transduction mechanism.
However, the anesthetic interactions are of such low affinity (lAM to mM) that ligand binding is not an option, and even the most successful mutagenesis study may not be able to define an "anesthetic receptor."
The question of whether a mutation directly alters the binding of the anesthetic to the chantiel or indirectly disrupts its effect on channel function is of particular importance to the differences between the G1uR3 and GluR6 receptors. Here the anesthetics act on both receptors, but the actions are opposite, and chimeric receptors will likely identify protein sequences that are responsible for transducing the action of the anesthetic rather than the binding of the anesthetic.
Despite concerns about the interpretation of these studies, they bring a truly molecular approach to the study of anesthetic action. It is possible that this strategy will succeed in identifying sequences that are common to "anesthetic-sensitive"
proteins. These may be found in other ion channels or proteins unrelated to known ion channels, making it possible to infer from sequence homology that a protein may be important for anesthesia.
CONCLUSIONS
At first glance, it appears that almost all subunit combinations of ligand-gated ion channels are sensitive to most anesthetics tested. This presents a looming shadow of nonspecificity at least as dark as that raised by Meyer and Overion (1) 
